|
Volumn 23, Issue 8, 2004, Pages 963-967
|
Predictive value of drug resistance-related genes expression in neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
GLYCOPROTEIN P;
LUNG RESISTANCE PROTEIN;
MULTIDRUG RESISTANCE PROTEIN;
NAVELBINE;
RIBONUCLEOPROTEIN;
TUMOR PROTEIN;
VINBLASTINE;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
FEMALE;
FOLLOW UP;
GENETICS;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
METABOLISM;
MIDDLE AGED;
MULTIDRUG RESISTANCE;
PREDICTION AND FORECASTING;
SURVIVAL RATE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
DEOXYCYTIDINE;
DRUG RESISTANCE, MULTIPLE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;
NEOADJUVANT THERAPY;
NEOPLASM PROTEINS;
NEOPLASM STAGING;
P-GLYCOPROTEIN;
PREDICTIVE VALUE OF TESTS;
SURVIVAL RATE;
VAULT RIBONUCLEOPROTEIN PARTICLES;
VINBLASTINE;
|
EID: 16644392165
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|